Tag
Cronos Group Inc
- Cronos Group enters the Swiss medical cannabis sector
- Schmidt retires, Cronos welcomes back Gorenstein as CEO
- Cronos reports US$134M Q4 net loss on closing of Peace Naturals facility
- Cronos releases delayed Q3 results, adds US$236.1M impairment charge
- Cronos continues to tumble after receiving Nasdaq delinquency letter
- Cronos continues cash burn with US$161M loss in Q1
- Organigram shares surge on big tobacco deal
- Cronos stock drops on US$111.7M Q4 loss
- Cronos stock pops despite rising losses
- Croptober 2020: Why a tsunami of Canadian outdoor will go up in smoke
- Crumbling Cronos enlists CPG CEO
- Amyris scales production of its first yeast-created cannabinoid
- Cronos stock craters on weak Canadian weed sales and US$107M loss
- Cronos continues to underwhelm in Q1, warns COVID‑19 will hamper sales
- CBD beauty market worth nearly US$1 billion by 2024: report
- Investors hold their breath as Tilray, Cronos lead cannabis earnings week with mixed results
- Market Capitalization Shrinks by $33.18 Billion For Top 10 Canadian Cannabis Companies Since Legalization